Show Notes
How do you cut 40% of the carbon out of a clinical trial without changing the price? You rent the equipment instead of buying it.
In this episode of the Sustainable Healthcare Podcast, part of our mini-series with the Sustainable Healthcare Coalition's Community of Practice for Clinical Trials, Frederik Dam van Deurs speaks with Alejandra Medina, Chief Sustainability Officer at Quipment, the French, B Corp-certified provider of equipment solutions for clinical trials.
About the guest: Alejandra Medina is Chief Sustainability Officer at Quipment SAS, a Nancy-based company founded in 2010 that equips and maintains clinical trial sites across 110+ countries. She joined as quality director and led Quipment through its B Corp certification.
Three things you'll take away: An equipment-rental ("equipment-as-a-service") model is circular by design: returning, reprocessing and redeploying devices keeps them in near-constant use across the value chain. - Quipment's benchmark, built for B Corp certification, shows a 40% carbon-footprint reduction moving from a linear to a circular model, comparable to the saving the Sustainable Markets Initiative estimates from more digital trials. - The real bottleneck for circularity isn't the technology, it's convincing the actors in the trial supply chain that circular is just as safe, compliant and high-performance as linear. Timestamps: 00:00 Introduction 02:00 Meet Alejandra: from Mexico to Nancy 03:00 What Quipment does: equipping and maintaining trial sites 05:00 The portfolio: ECGs, infusion pumps, data loggers and 3,000+ products 07:00 Becoming a B Corp: how the assessment revealed a circular model 09:00 Circular by design: rent, return, reprocess, redeploy 13:00 Where circularity breaks down in clinical trials 16:00 The cost question: services at the same price 18:00 Informing the choice: tools over mandates 19:00 The Quipment Carbon Compass: a comparator, not a calculator 20:00 40% carbon reduction, linear vs circular 23:00 The new seven-pillar B Corp standard 25:00 What gives Alejandra hope
References and links: Sustainable Healthcare Coalition, Community of Practice for Clinical Trials: https://shcoalition.org/sustainable-clinical-trials-knowledge-hub/ B Corp certification (B Lab): https://www.bcorporation.net/ Quipment B Corp profile: https://www.bcorporation.net/en-us/find-a-b-corp/company/quipment-sas/ Alejandra Medina on LinkedIn: https://fr.linkedin.com/in/alejandra-medina-3315185 Quipment: https://www.quipment.com/
You might also enjoy: Episode 102, Sustainable Clinical Trials (1): Convien & myoncare with Christian Hieronimi: https://carepathwayconsulting.com/podcast/podcast-episode-102/
Host links: Joachim Almdal on LinkedIn: https://www.linkedin.com/in/joachim-espeland-almdal-017a6973/ Frederik van Deurs on LinkedIn: https://www.linkedin.com/in/frederikvandeurs/ Care Pathway Consulting: https://carepathwayconsulting.com
"Quipment Carbon Compass isn't a calculator, it's a comparator. We didn't change anything; we just changed the way we explain our business. We were circular by design from the beginning." - Alejandra Medina
More from The Sustainable Healthcare Podcast
Most work on greener medication starts with the waste bin. This episode goes one step upstream, to the moment a medicine is prescribed at all, and in which form. Lisa-Marie Smale and Nicole Hunfeld explain what 63 Dutch doctors and pharmacists agreed to change about prescribing, why a tablet can beat a drip, and where a stop date gets lost on the way home.
Hospitals use many single-use products.
What happens when you move acute hospital care into the patient's own home? Maria Normand Larsen shares the results of Denmark's first hospital-at-home randomised trial.
If we want to fix sustainability in healthcare, one of the most powerful levers sits at the gate where new health technologies get approved: Health Technology Assessment (HTA).
Structured Material Selection: Building Sustainable Medical Devices with Plastics How do you make a medical device more sustainable without blowing up the business case? Lucas Pianegonda breaks down the structured way to choose plastics, and why the first win is usually deleting a requirement, not changing a material.